Income Taxes - Additional Information (Detail) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Income Taxes [Line Items] | |||
| Valuation allowance | $ 37,013,000 | $ 32,299,000 | $ 56,045,000 |
| GILTI income from continuing operations | $ 0 | 0 | |
| Operating loss carryforwards, expiration end year | 2045 | ||
| Liabilities for unrecognized tax benefits | $ 2,100,000 | $ 2,300,000 | |
| Research and experimental cost amortization period | 5 years | ||
| Unrecognized tax benefits related to deferred tax assets due to changes in expected settlement periods | $ 700,000 | ||
| Federal | |||
| Income Taxes [Line Items] | |||
| Operating loss carryforwards | 96,500,000 | ||
| State | |||
| Income Taxes [Line Items] | |||
| Operating loss carryforwards | $ 46,500,000 | ||
| Research and experimental cost amortization period | 5 years | ||
| Foreign | |||
| Income Taxes [Line Items] | |||
| Operating loss carryforwards | $ 52,100,000 | ||
| Research and experimental cost amortization period | 15 years | ||